Cargando…
Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review
BACKGROUND: There is currently at least 1 biologic (adalimumab) approved in North America for treatment of Hidradenitis Suppurativa in the pediatric population. However, no reviews or clinical trials have specifically analyzed the effectiveness and safety data of biologic use in this population. The...
Autores principales: | Sachdeva, Muskaan, Kim, Patrick, Mufti, Asfandyar, Maliyar, Khalad, Sibbald, Cathryn, Alavi, Afsaneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978460/ https://www.ncbi.nlm.nih.gov/pubmed/34587768 http://dx.doi.org/10.1177/12034754211049711 |
Ejemplares similares
-
Squamous cell carcinoma arising within discoid lupus erythematous lesions: A systematic review
por: Mufti, Asfandyar, et al.
Publicado: (2020) -
COVID-19 and wound care: A Canadian perspective
por: Mufti, Asfandyar, et al.
Publicado: (2020) -
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
por: Sachdeva, Muskaan, et al.
Publicado: (2020) -
Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020) -
Modifications to dermatology residency education during the COVID-19 pandemic
por: Mufti, Asfandyar, et al.
Publicado: (2020)